| Literature DB >> 31821150 |
Damian Hacking1, Zodwa Mgengwana-Mbakaza1, Tali Cassidy1, Pumeza Runeyi1, Laura Trivino Duran1, Andrew Boulle2, Ruth Henwood Mathys1.
Abstract
BACKGROUND: Youths in South Africa are poor utilizers of HIV health services. Medecins Sans Frontieres has been piloting youth-adapted services at a youth clinic in Khayelitsha, including a peer virtual mentorship program over mobile phones, piloted from March 2015 to May 2016.Entities:
Keywords: HIV; mobile phone; patient navigator; peer influence; retention in care; youth
Year: 2019 PMID: 31821150 PMCID: PMC6930512 DOI: 10.2196/14012
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Descriptive data outcomes measured in mentees and matched controls.
| Outcome to be measured | Calculation |
| Linkage to ARTa care | Number of patients who tested positive and initiated ART/number of patients tested positive |
| Median time to linkage to ART care | Of those who initiated ART, difference between the date of HIV counseling and testing and the date of ART initiation |
| Median time out of care pre-ART | Of those who did not link within the first 6 months, total number of days late for pre-ART appointments |
| Retention in care on ART | Number of patients retained in care at 6 and 12 months/number of patients who initiated ART |
| Viral load completion | Number of viral load results available/number due for a viral load at 4 months |
| Viral load suppression | Number of patients with suppressed viral load (<400 copies/ml)/number of viral load results available |
aART: antiretroviral therapy.
Figure 1Exclusion criteria flow diagram. HCT: HIV counseling and testing; LTF: lost to follow-up; mo: months; RIC: retention in care; TFO: transferred out; ART: antiretroviral therapy.
Demographic data between groups.
| Demographic | Virtual mentees cohort (N=40) | Matched controls cohort (N=70) | |
|
| |||
|
| Male | 2 (5) | 6 (9) |
|
| Female | 38 (95) | 64 (91) |
| Age at diagnosis, median (IQRa) | 20 years 5 months (3 years 4 months) | 22 years 7 months (3 years 6 months) | |
| Baseline CD4, median (IQR); n | 496 (378-592); 29 | 443 (307-638); 6 | |
aIQR: interquartile range.
Figure 2Antiviral therapy initiation, retention, and viral load completion by group. ART: antiretroviral therapy; VL 1: first viral load.
Linkage, retention in care, and viral load outcomes.
| Metric | Virtual mentors (VM) | Matched controls (MC) |
| Linkage to ARTa care, n (%) | 28 (80) | 30 (43) |
| Of those linked, Days to linkage to ART care, median (IQRb) | 217.5 (32.5-467.75) | 49.5 (7-333.25) |
| Days out of care pre-ART, median (IQR); n | 38 (1-350); 17 | 200 (29-337.5); 11 |
| Retention in care on ART at 6 months (for VM, N=45; for MC, N=19), n (%) | 23 (92) | 17 (89) |
| Retention in care on ART at 12 months (for VM, N=22; for MC, N=16), n (%) | 22 (100) | 15 (94) |
| First viral load completion (for VM, N=35; for MC, N=70), n (%) | 28 (80) | 32 (45) |
| First viral load suppression (<400 copies/ml; for VM, N=28; for MC, N=32), n (%) | 26 (93) | 29 (91) |
aART: antiretroviral therapy.
bIQR: interquartile range.